Children Requiring IV PlacementNCT02326623
Distraction to Reduce Pain and Distress in the Pediatric Emergency Department
A study testing distraction and topical anesthetic cream in people with Children Requiring IV Placement, run by University of Alberta at 1 site in Canada.
Trial summary
Many medical procedures aimed at helping children can cause them pain and distress. If children have certain levels of pain or distress, it can have long lasting negative effects. The emergency department can be a very stressful place for children and their parents. Read more about this study
- Who is it for?
- Ages 6 to 11 years
- Conditions the study is for
- Children Requiring IV Placement
- What is being tested?
- distraction and topical anesthetic cream
- Type of treatment
- Injection or infusion
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 85 participants
- Where
- 1 siteCanada
- Study dates
- Oct 2015to 30 Jul 2018
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 6 to 11 years
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- attending pediatric emergency department
- require IV placement
- fully conscious and alert
- have sufficient knowledge of the English language to understand and complete the pain assessments
Who cannot join
- hearing or visual impairments
- neurocognitive delays
- sensory impairment to pain (e.g., spina bifida)
- at the discretion of the attending staff (e.g., child in critical condition)
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Distraction to Reduce Pain and Distress: A Randomized Controlled Trial of Children Undergoing Intravenous Placement in the Pediatric Emergency Department
Many medical procedures aimed at helping children can cause them pain and distress. If children have certain levels of pain or distress, it can have long lasting negative effects. The emergency department can be a very stressful place for children and their parents. There are also many procedures that children may have in the emergency department that can cause pain and distress. These include procedures such as needle pokes, stitches, or setting a broken bone. Two common methods of managing a child's pain in the emergency department are drugs and distraction. Drugs are not always practical and may come with unwanted side effects. Distraction is often used by parents or health professionals to help children deal with pain and stress. Distraction can lower the child's pain and distress by moving their attention from the painful experience, for example a needle poke, to a more positive feeling such as watching a movie, playing a game, or listening to music. This study will test if iPads are useful to help lower pain and distress for children (ages 6 to 11 years) who are visiting an emergency department and need an intravenous line put in. The results from this study could be important for many children receiving medical care, as distraction is safe and the use of iPads is enjoyable for many children.
Read the detailed description
Setting and Study Period: The study will be conducted in the ED of the Stollery Children's Hospital. Patient recruitment is projected to begin in October 2014 and continue to March 2015.
Study Design and Population: The study will be a RCT; the primary outcomes will be the child's self-reported pain and observed behavioural distress. The population is children, ages 6 to 11 years, attending a pediatric ED and requiring IV placement.
Recruitment: Research assistants (RAs) will identify patients attending the ED between the ages of 6 and 11 years. A RA will be on-site from approximately 14:00 to 22:00 daily to identify children who require IV placement; this time corresponds with peak visits requiring IV placements based on data collected in the ED at the Stollery Children's Hospital in team members' previous studies. For those who require IV placement, the RA will further assess child eligibility based on the inclusion / exclusion criteria outlined below. If the child is eligible, the RA will explain the study and invite the parent and child to participate. After obtaining written, informed consent from the parent and assent from the child, the RA will open a prepared randomization envelope and assign the child to one of the two intervention arms. The RA will ask one parent or caregiver for each child to participate and complete all relevant questionnaires.
Baseline Assessment: After informed consent/assent is obtained, the RA will gather information from the parent on baseline demographic variables (e.g., gender, age), presenting signs and symptoms (e.g., chief complaint), and previous history with ED visits and IV placement.
Randomization, Allocation, and Blinding of Study Treatment: Randomization method: A statistician will prepare the randomization sequence using appropriate software and prepare the envelopes. Allocation will be concealed from the RAs, ED staff, child and parent until consent/assent has been obtained. The statistician will maintain the randomization code which will not be broken until data analysis is complete. Allocation: After receiving informed consent/assent, the RA will open the next envelope in a series of consecutively labeled, sealed, opaque envelopes. These will be kept in a secured location in the ED research office. Blinding: Due to the nature of the intervention, it will not be possible to blind the children, parents, or research and ED staff. The children and their parents will be informed that the study is to evaluate different forms of distraction but will not know the study hypothesis for iPads nor what each group is receiving. The data analyst will be blind to treatment assignment through the use of randomization codes that will not be disclosed until analysis is complete.
Study Intervention and Comparison: The intervention will be the use of an iPad that will include a selection of child-appropriate games. We will select popular, age-appropriate items to include on the iPad, chosen based on the most current online consumer ratings. Children and parents will be able to select their choice of distraction and can change their selection as desired during the course of the procedure. These choices will be recorded for study purposes. The control group will receive standard care, which generally includes the use of topical anesthetic cream. This comparison is based on the pragmatic preferences of physicians at the Stollery Children's Hospital as well as precedent in the literature. Overall, it is felt that any new intervention (e.g., iPad) should be compared to what is currently in practice (i.e., standard care), as no single distraction therapy is consistently and routinely employed in EDs at this time.
Study Outcomes: The primary outcomes are patient pain and distress. Self-reported pain will be measured using the Faces Pain Scale-Revised (FPS-R). This measurement will be made immediately following the initial attempt at IV placement. The FPS-R is the currently recommended pain scale for our participant group with strong evidence of validity and reliability for our age range. Distress will be measured using the Observed Scale of Behavioral Distress-Revised (OSBD-R); a tool designed to assess a child's behavioural response to painful medical procedures. The scale scores are reliable and valid for our target population. Two research students will be trained in the use of the tool and will independently observe a videotape of each child and record the frequency of operationally-defined distress-related behaviours during continuous 15-second intervals before, during, and after the procedure. This protocol for use of the OSBD-R is standard; it has been used in other trials evaluating distraction, including a trial by one of the PIs (LH) evaluating music. The secondary outcomes are (a) observed pain which will be measured by the research students using a standard 100 mm visual analogue scale; (b) parent and provider satisfaction (measured using Likert scales); (c) ease of performing the procedure assessed by the provider; time to complete the procedure; (d) success of the procedure; and (e) parent state anxiety measured with a validated instrument, the State Trait Anxiety Inventory (STAI-S, Form Y).
- Conditions
- Children Requiring IV Placement
- Being tested
- distraction, topical anesthetic cream
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
distractionOther
distraction using an iPad with a selection of child-appropriate games
topical anesthetic creamOther
standard care is to use a topical anesthetic cream at the site of planning IV access
| Study group | Role | What they receive |
|---|---|---|
| iPad distraction | Experimental | The intervention will be the use of an iPad that will include a selection of child-appropriate games. We will select popular, age-appropriate items to include on the iPad, chosen based on the most current online consumer ratings. Children and parents will be able to select their choice of distraction and can change their selection as desired during the course of the procedure. These choices will be recorded for study purposes. Receives: Other: distraction |
| standard care | Other | The control group will receive standard care, which generally includes the use of topical anesthetic cream. Receives: Other: topical anesthetic cream |
What is being measured
The primary outcome is the main question the study is designed to answer.
pain (self report) Faces Pain Scale-Revised (FPS-R)
Faces Pain Scale-Revised (FPS-R)
Measured: at time of IV placement, Day 1
distress Observed Scale of Behavioral Distress-Revised (OSBD-R)
Observed Scale of Behavioral Distress-Revised (OSBD-R)
Measured: at time of IV placement, Day 1
Secondary outcomes (5)
pain (observed) visual analogue scale
measured by the research students using a standard 100 mm visual analogue scale
Measured: at time of IV placement, Day 1
parent and provider satisfaction (Likert scale)
Likert scale
Measured: 2 minutes post IV placement, Day 1
ease of procedure performance (assessed by provider)
assessed by provider
Measured: at time of IV placement, Day 1
success of procedure (assessed by provider)
assessed by provider
Measured: at time of IV placement, Day 1
parent anxiety (State Trait Anxiety Inventory (STAI-S, Form Y)
State Trait Anxiety Inventory (STAI-S, Form Y)
Measured: at time of IV placment, Day 1
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Dec 2014 (estimated)
- Study startOct 2015
- Primary completionDec 2016
- Study completion30 Jul 2018
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Children Requiring IV PlacementStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 85 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Alberta
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Samina Ali, MD, Principal investigator, University of Alberta/Stollery Children's Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02326623
- Sponsor's protocol ID
- Pro00050791
- Status last verified
- Feb 2017
- First submitted
- 10 Oct 2014
- Last updated
- 1 Aug 2018
- Results posted
- No
- Data monitoring committee
- No
Publications
Ali S, Ma K, Dow N, Vandermeer B, Scott S, Beran T, Issawi A, Curtis S, Jou H, Graham TAD, Sigismund L, Hartling L. A randomized trial of iPad distraction to reduce children's pain and distress during intravenous cannulation in the paediatric emergency department. Paediatr Child Health. 2020 Aug 20;26(5):287-293. doi: 10.1093/pch/pxaa089. eCollection 2021 Aug.
PubMed 34630780
Study at a glance
From the registry record, last updated by the sponsor on 1 Aug 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Distraction to Reduce Pain and Distress: A Randomized Controlled Trial of Children Undergoing Intravenous Placement in the Pediatric Emergency Department
- ClinicalTrials.gov ID
- NCT02326623
- Acronym / sponsor ID
- Pro00050791
- Conditions
- Children Requiring IV Placement
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 85 participants (actual)
- Lead sponsor
- University of AlbertaUniversity, hospital or other
- Study start
- Oct 2015
- Primary completion
- Dec 2016 (actual)
- Study completion
- 30 Jul 2018 (actual)
- First posted
- 29 Dec 2014 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Many medical procedures aimed at helping children can cause them pain and distress. If children have certain levels of pain or distress, it can have long lasting negative effects. The emergency department can be a very stressful place for children and their parents. There are also many procedures that children may have in the emergency department that can cause pain and distress. These include procedures such as needle pokes, stitches, or setting a broken bone. Two common methods of managing a child's pain in the emergency department are drugs and distraction. Drugs are not always practical and may come with unwanted side effects. Distraction is often used by parents or health professionals to help children deal with pain and stress. Distraction can lower the child's pain and distress by moving their attention from the painful experience, for example a needle poke, to a more positive feeling such as watching a movie, playing a game, or listening to music. This study will test if iPads are useful to help lower pain and distress for children (ages 6 to 11 years) who are visiting an emergency department and need an intravenous line put in. The results from this study could be important for many children receiving medical care, as distraction is safe and the use of iPads is enjoyable for many children.
Detailed description
Setting and Study Period: The study will be conducted in the ED of the Stollery Children's Hospital. Patient recruitment is projected to begin in October 2014 and continue to March 2015.
Study Design and Population: The study will be a RCT; the primary outcomes will be the child's self-reported pain and observed behavioural distress. The population is children, ages 6 to 11 years, attending a pediatric ED and requiring IV placement.
Recruitment: Research assistants (RAs) will identify patients attending the ED between the ages of 6 and 11 years. A RA will be on-site from approximately 14:00 to 22:00 daily to identify children who require IV placement; this time corresponds with peak visits requiring IV placements based on data collected in the ED at the Stollery Children's Hospital in team members' previous studies. For those who require IV placement, the RA will further assess child eligibility based on the inclusion / exclusion criteria outlined below. If the child is eligible, the RA will explain the study and invite the parent and child to participate. After obtaining written, informed consent from the parent and assent from the child, the RA will open a prepared randomization envelope and assign the child to one of the two intervention arms. The RA will ask one parent or caregiver for each child to participate and complete all relevant questionnaires.
Baseline Assessment: After informed consent/assent is obtained, the RA will gather information from the parent on baseline demographic variables (e.g., gender, age), presenting signs and symptoms (e.g., chief complaint), and previous history with ED visits and IV placement.
Randomization, Allocation, and Blinding of Study Treatment: Randomization method: A statistician will prepare the randomization sequence using appropriate software and prepare the envelopes. Allocation will be concealed from the RAs, ED staff, child and parent until consent/assent has been obtained. The statistician will maintain the randomization code which will not be broken until data analysis is complete. Allocation: After receiving informed consent/assent, the RA will open the next envelope in a series of consecutively labeled, sealed, opaque envelopes. These will be kept in a secured location in the ED research office. Blinding: Due to the nature of the intervention, it will not be possible to blind the children, parents, or research and ED staff. The children and their parents will be informed that the study is to evaluate different forms of distraction but will not know the study hypothesis for iPads nor what each group is receiving. The data analyst will be blind to treatment assignment through the use of randomization codes that will not be disclosed until analysis is complete.
Study Intervention and Comparison: The intervention will be the use of an iPad that will include a selection of child-appropriate games. We will select popular, age-appropriate items to include on the iPad, chosen based on the most current online consumer ratings. Children and parents will be able to select their choice of distraction and can change their selection as desired during the course of the procedure. These choices will be recorded for study purposes. The control group will receive standard care, which generally includes the use of topical anesthetic cream. This comparison is based on the pragmatic preferences of physicians at the Stollery Children's Hospital as well as precedent in the literature. Overall, it is felt that any new intervention (e.g., iPad) should be compared to what is currently in practice (i.e., standard care), as no single distraction therapy is consistently and routinely employed in EDs at this time.
Study Outcomes: The primary outcomes are patient pain and distress. Self-reported pain will be measured using the Faces Pain Scale-Revised (FPS-R). This measurement will be made immediately following the initial attempt at IV placement. The FPS-R is the currently recommended pain scale for our participant group with strong evidence of validity and reliability for our age range. Distress will be measured using the Observed Scale of Behavioral Distress-Revised (OSBD-R); a tool designed to assess a child's behavioural response to painful medical procedures. The scale scores are reliable and valid for our target population. Two research students will be trained in the use of the tool and will independently observe a videotape of each child and record the frequency of operationally-defined distress-related behaviours during continuous 15-second intervals before, during, and after the procedure. This protocol for use of the OSBD-R is standard; it has been used in other trials evaluating distraction, including a trial by one of the PIs (LH) evaluating music. The secondary outcomes are (a) observed pain which will be measured by the research students using a standard 100 mm visual analogue scale; (b) parent and provider satisfaction (measured using Likert scales); (c) ease of performing the procedure assessed by the provider; time to complete the procedure; (d) success of the procedure; and (e) parent state anxiety measured with a validated instrument, the State Trait Anxiety Inventory (STAI-S, Form Y).
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| iPad distraction | Experimental | Other: distractionThe intervention will be the use of an iPad that will include a selection of child-appropriate games. We will select popular, age-appropriate items to include on the iPad, chosen based on the most current online consumer ratings. Children and parents will be able to select their choice of distraction and can change their selection as desired during the course of the procedure. These choices will be recorded for study purposes. |
| standard care | Other | Other: topical anesthetic creamThe control group will receive standard care, which generally includes the use of topical anesthetic cream. |
Who may qualify
- Ages
- 6 to 11 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (4 listed)
- attending pediatric emergency department
- require IV placement
- fully conscious and alert
- have sufficient knowledge of the English language to understand and complete the pain assessments
Key exclusion criteria (4 listed)
- hearing or visual impairments
- neurocognitive delays
- sensory impairment to pain (e.g., spina bifida)
- at the discretion of the attending staff (e.g., child in critical condition)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| distractiondistraction using an iPad with a selection of child-appropriate games | Other | iPad distraction |
| topical anesthetic creamstandard care is to use a topical anesthetic cream at the site of planning IV access | Other | standard care |
Primary outcome
pain (self report) Faces Pain Scale-Revised (FPS-R)
Time frame: at time of IV placement, Day 1
Faces Pain Scale-Revised (FPS-R)
distress Observed Scale of Behavioral Distress-Revised (OSBD-R)
Time frame: at time of IV placement, Day 1
Observed Scale of Behavioral Distress-Revised (OSBD-R)
5 secondary outcomes
pain (observed) visual analogue scale
Time frame: at time of IV placement, Day 1
parent and provider satisfaction (Likert scale)
Time frame: 2 minutes post IV placement, Day 1
ease of procedure performance (assessed by provider)
Time frame: at time of IV placement, Day 1
success of procedure (assessed by provider)
Time frame: at time of IV placement, Day 1
parent anxiety (State Trait Anxiety Inventory (STAI-S, Form Y)
Time frame: at time of IV placment, Day 1
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Aug 2018.
- Derived from this study: PubMed 34630780Ali S, Ma K, Dow N, Vandermeer B, Scott S, Beran T, Issawi A, Curtis S, Jou H, Graham TAD, Sigismund L, Hartling L. A randomized trial of iPad distraction to reduce children's pain and distress during intravenous cannulation in the paediatric emergency department. Paediatr Child Health. 2020 Aug 20;26(5):287-293. doi: 10.1093/pch/pxaa089. eCollection 2021 Aug.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Samina Ali, MD principal investigator
University of Alberta/Stollery Children's Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing distraction and topical anesthetic cream in people with Children Requiring IV Placement, run by University of Alberta at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 1 Aug 2018. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
pain (self report) Faces Pain Scale-Revised (FPS-R) (time frame: at time of IV placement, Day 1). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02326623, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Aug 2018.